Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ayahuasca-assisted psychotherapy for grief
NCT06150859Phase 2Enrolling by invitation
- Sponsor
- The Beckley Foundation
- Start
- Oct 2021
- Primary completion
- Apr 2024
- Modality
- Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ayahuasca in prolonged grief disorder (PGD), sponsored by The Beckley Foundation. Started Oct 2021; status: enrolling by invitation.
02
Drugs
ayahuasca
03
Conditions
prolonged grief disorder (PGD)
Beyond the preview
Go deeper on NCT06150859.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06150859.